Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients
- 10 December 1998
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 25 (9) , 993-997
- https://doi.org/10.1016/s0891-5849(98)00118-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus ChronicityHepatology, 1997
- Hepatitis C virus (HCV) genotype analysis in apparently healthy anti‐ HCV‐positive Parisian blood donorsTransfusion, 1996
- Asymptomatic infection with hepatitis C virusBMJ, 1994
- Interferon decreases serum lipid peroxidation products of hepatitis C patientsFree Radical Biology & Medicine, 1994
- Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology & Medicine, 1991
- Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- Lipid peroxides and human diseasesChemistry and Physics of Lipids, 1987
- Lipid Peroxidation in Alcoholic Liver Disease in HumansAlcohol, Clinical and Experimental Research, 1981
- Serum lipoperoxide level in patients suffering from liver diseasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITISThe Lancet, 1975